SCHEMBL2274012

SCHEMBL2274012

O=C(Nc1cc(-c2ccc3c(c2)OCO3)ccc1C(=O)O)c1nc2ccccc2s1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 1/20 0.59
KDM4E B2RXH2 8/20 0.57
ALDH1A1 P00352 7/20 0.57
HPGD P15428 6/20 0.57
MEN1 O00255 6/20 0.57
KMT2A Q03164 6/20 0.57
NPSR1 Q6W5P4 3/20 0.57
CYP1A2 P05177 2/20 0.57
CYP3A4 P08684 2/20 0.57
CYP2C9 P11712 2/20 0.57
CYP2C19 P33261 2/20 0.57
TP53 P04637 3/20 0.54
DHODH Q02127 1/20 0.54
GLO1 Q04760 1/20 0.54
MAPT P10636 6/20 0.54
LMNA P02545 5/20 0.54
NPC1 O15118 4/20 0.54
RAB9A P51151 4/20 0.54
SMN1; SMN2 Q16637 4/20 0.54
NFKB1 P19838 3/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2275537 0.86 HDAC1 (0.78) HDAC1KDM4EALDH1A1HPGDMEN1
SCHEMBL2273799 0.83 HDAC1 (0.73) HDAC1KDM4EALDH1A1HPGDMEN1
SCHEMBL2274795 0.81 NPC1 (0.60) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL2270969 0.80 HDAC1 (0.65) HDAC1KDM4EHPGDMEN1KMT2A
SCHEMBL2272541 0.78 PTGS2 (0.63) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL2275030 0.78 MEN1 (0.61) HDAC1KDM4EALDH1A1HPGDMEN1
SCHEMBL2273182 0.77 PTGS2 (0.66) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL2274032 0.76 HDAC1 (0.56) HDAC1KDM4EALDH1A1HPGDMEN1
SCHEMBL2271790 0.75 SMN1; SMN2 (0.56) HDAC1KDM4EALDH1A1HPGDMEN1
SCHEMBL2271243 0.74 ADCY1 (0.61) KDM4EALDH1A1HPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7999132-B2 Anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2011-08-16 US disclosed
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-09-24 US disclosed
EP-1820795-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2007-08-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF MMP13, MMP26, MMP11 HDAC1 71/4885KDM4E 1257/4885ALDH1A1 645/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.